Characteristics of Blood Glucose Variability in Patients With Type 2 Diabetes Mellitus and COVID-19

Launched by QILU HOSPITAL OF SHANDONG UNIVERSITY · Nov 24, 2023

Keywords

ClinConnect Summary

This clinical trial is studying how blood sugar levels change in patients with type 2 diabetes who also have COVID-19 pneumonia. By using a special device that continuously monitors blood sugar, researchers hope to better understand how these fluctuations affect patients' health and recovery. The goal is to find better ways to manage blood sugar to improve patient outcomes, shorten hospital stays, and reduce healthcare costs.

To participate in this study, individuals must have been diagnosed with type 2 diabetes and have mild to severe COVID-19. Participants will be monitored during their hospital stay using the glucose monitoring device. This research aims to identify the best blood sugar targets for these patients and see how those targets relate to their recovery from COVID-19. If you or someone you know meets these criteria and is interested, this trial could provide valuable information for managing diabetes in the context of COVID-19.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. All patients met the diagnostic criteria of type 2 diabetes mellitus in "Chinese Guidelines for the Prevention and treatment of type 2 Diabetes Mellitus (2020 edition)" formulated by the Chinese Diabetes Society of the Chinese Medical Association, and were previously diagnosed with type 2 diabetes mellitus and newly diagnosed with type 2 diabetes mellitus after admission
• • 2. Patients with mild, moderate, severe and critical COVID-19 in accordance with the guidelines of "Diagnosis and Treatment of novel coronavirus Infection (Trial version 10)"
• • 3. Patients receiving CGM or peripheral blood glucose monitoring during hospitalization
• Exclusion Criteria:
• • 1. Cases with incomplete data
• • 2. Non-NCP and non-T2DM patients
• • 3. Patients who did not receive CGM or peripheral blood glucose monitoring